Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

Message from the President

Message from the President

In July, the ALTG hosted the Annual Scientific Meeting, its fourth Lung Cancer symposium focusing on the theme of “Delivering Precision Medicine for Lung Cancer”. The two-day program featured local and international experts delivering presentations on patient-focused care, survivorship and host factors for immunotherapy and targeted therapy – with record-breaking attendance. Highlights included presentations by Dr Alexander Drilon, from Memorial Sloan Kettering Cancer Centre, on “Precision medicine in lung cancer” and “RET/NTRK targets in lung cancer”, and by Professor Jolie Qing Zhou, from Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, on “EGFR sequencing in the context of resistance”. For the first time the program included a dedicated session on abstract oral presentations, and I warmly congratulate Dr Pei Ding on receiving the ALTG Young Investigator Award, and Dr Christopher Cao on receiving the ALTG Annual Scientific Meeting Abstract Award. On behalf of the ALTG, I extend my thanks to the Local Organising Committee, chairs, speakers, staff and sponsors who contributed.

ALTG President A/Prof Nick Pavlakis presenting Dr Pei Ding with the ALTG Young Investigator Award

I would also like to welcome Megan Sanders to the role of ALTG Executive Officer. Megan has previously worked for nine years at the Australasian Leukaemia and Lymphoma Group (ALLG), initially as Protocol Development Coordinator and then as Program Manager, managing the ALLG portfolio in blood cancer clinical trials, and establishing and managing the ALLG ‘in house’ Trial Centre. For the last year, Megan was employed at the Australian Clinical Trials Alliance (ACTA) as a Senior Project Officer working on effective clinical trial network operations and establishment of new clinical trials groups in various areas of healthcare. Megan can be contacted for any ALTG queries on megans@lungfoundation.com.au. Thanks to Kelcie Herrmann who assisted the ALTG in an interim capacity during recruitment to the ALTG Executive Officer position.

Finally, the ALTG Management Advisory Committee and Scientific Advisory Committee extend a warm invite to anyone wishing to attend the next open meetings on 8 November in Sydney. Please keep an eye on your inbox or contact altg@lungfoundation.com.au for more details.

Kind regards,

A/Prof Nick Pavlakis

ALTG President